The Headline Everyone’s Missing You’ve probably heard the numbers by now. Semaglutide and tirzepatide have become household names, splashed across magazine covers and late-night comedy sketches. The cultural conversation is entirely dominated by weight loss, which makes sense—these drugs work, people are getting results, and pharmaceutical revenues have entered the stratosphere. Novo Nordisk’s combined sales…



